Y Intercept Hong Kong Ltd Sells 4,727 Shares of HCA Healthcare, Inc. (NYSE:HCA)

Y Intercept Hong Kong Ltd decreased its stake in shares of HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 44.0% in the 3rd quarter, according to its most recent 13F filing with the SEC. The firm owned 6,016 shares of the company's stock after selling 4,727 shares during the period. Y Intercept Hong Kong Ltd's holdings in HCA Healthcare were worth $2,445,000 as of its most recent filing with the SEC.

Several other hedge funds have also recently bought and sold shares of HCA. MML Investors Services LLC boosted its stake in HCA Healthcare by 31.7% in the 3rd quarter. MML Investors Services LLC now owns 17,816 shares of the company's stock valued at $7,241,000 after purchasing an additional 4,285 shares during the period. Legacy Investment Solutions LLC acquired a new position in shares of HCA Healthcare in the third quarter valued at about $39,000. Orion Portfolio Solutions LLC raised its stake in HCA Healthcare by 3.3% in the 3rd quarter. Orion Portfolio Solutions LLC now owns 6,735 shares of the company's stock worth $2,737,000 after purchasing an additional 216 shares in the last quarter. Zacks Investment Management increased its holdings in shares of HCA Healthcare by 3.2% during the third quarter. Zacks Investment Management now owns 62,117 shares of the company's stock worth $25,246,000 after purchasing an additional 1,942 shares during the period. Finally, National Bank of Canada FI boosted its stake in shares of HCA Healthcare by 53.4% in the third quarter. National Bank of Canada FI now owns 155,878 shares of the company's stock valued at $63,353,000 after buying an additional 54,293 shares during the period. 62.73% of the stock is currently owned by institutional investors and hedge funds.

HCA Healthcare Trading Down 0.5 %

Shares of NYSE HCA traded down $1.72 during midday trading on Tuesday, reaching $316.78. The stock had a trading volume of 1,087,360 shares, compared to its average volume of 1,203,334. HCA Healthcare, Inc. has a twelve month low of $255.73 and a twelve month high of $417.14. The company's 50 day moving average price is $362.09 and its 200 day moving average price is $358.91. The firm has a market cap of $80.24 billion, a price-to-earnings ratio of 14.22, a price-to-earnings-growth ratio of 1.23 and a beta of 1.63. The company has a debt-to-equity ratio of 48.71, a quick ratio of 1.00 and a current ratio of 1.12.

HCA Healthcare Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, December 27th. Stockholders of record on Friday, December 13th will be issued a dividend of $0.66 per share. The ex-dividend date of this dividend is Friday, December 13th. This represents a $2.64 annualized dividend and a dividend yield of 0.83%. HCA Healthcare's dividend payout ratio is 11.85%.

Wall Street Analyst Weigh In

A number of analysts have recently weighed in on the company. Cantor Fitzgerald reiterated an "overweight" rating and set a $392.00 target price on shares of HCA Healthcare in a research report on Tuesday, October 1st. TD Cowen cut their price target on shares of HCA Healthcare from $450.00 to $440.00 and set a "buy" rating for the company in a report on Monday, October 28th. UBS Group upped their target price on HCA Healthcare from $405.00 to $438.00 and gave the stock a "buy" rating in a research note on Wednesday, August 14th. KeyCorp lowered their price target on HCA Healthcare from $475.00 to $420.00 and set an "overweight" rating for the company in a report on Monday, October 28th. Finally, Royal Bank of Canada lifted their target price on HCA Healthcare from $378.00 to $405.00 and gave the company an "outperform" rating in a research report on Friday, August 23rd. One research analyst has rated the stock with a sell rating, five have assigned a hold rating, twelve have given a buy rating and two have given a strong buy rating to the stock. According to data from MarketBeat, the stock has an average rating of "Moderate Buy" and a consensus target price of $380.29.

Insider Activity at HCA Healthcare

In other news, insider Erol R. Akdamar sold 2,900 shares of HCA Healthcare stock in a transaction on Thursday, November 14th. The stock was sold at an average price of $353.00, for a total value of $1,023,700.00. Following the completion of the transaction, the insider now directly owns 6,843 shares in the company, valued at approximately $2,415,579. The trade was a 29.76 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, SVP Phillip G. Billington sold 3,897 shares of the firm's stock in a transaction dated Thursday, November 14th. The stock was sold at an average price of $350.00, for a total value of $1,363,950.00. Following the completion of the transaction, the senior vice president now owns 52,702 shares of the company's stock, valued at approximately $18,445,700. This represents a 6.89 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 15,155 shares of company stock valued at $5,608,990 over the last 90 days. Insiders own 1.70% of the company's stock.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.